Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463926 | SCV000545480 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573540 | SCV000661611 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000573540 | SCV000908756 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653825 | SCV001861660 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573540 | SCV002529108 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-01 | criteria provided, single submitter | curation | |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV000463926 | SCV003926897 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | Not applicable criteria (PMID: 30311375) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230497 | SCV003929362 | likely benign | not specified | 2023-04-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001653825 | SCV004140033 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | CDH1: BP4, BP7 |
Myriad Genetics, |
RCV000463926 | SCV005405075 | benign | Hereditary diffuse gastric adenocarcinoma | 2024-09-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |